Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient